摘要
目的探讨环氧合酶-2抑制剂对高体积分数氧(高氧)环境下新生大鼠肺组织肺表面活性物质相关蛋白B(SP-B)、转化生长因子-β1(TGF-β1)表达的影响。方法将新生SD大鼠105只按随机数字表法分为3组(每组35只):空气组(I组)大鼠置于空气中;高氧组(Ⅱ组)置于850mL/L氧气中;塞来昔布干预组(Ⅲ组)置于850mL/L氧气,每天腹腔注射塞来昔布5mg/kg。于出生3、7、14d处死大鼠,右下肺组织HE染色,光镜下观察其病理学改变;左肺进行肺灌洗,酶联免疫吸附试验(ELISA)检测支气管肺泡灌洗液SP-B、TGF-β1水平;右上肺组织一部分进行免疫组织化学检测,光镜观察肺组织SP-B、TGF-β1表达,一部分进行实时荧光定量聚合酶链反应(RT-PCR)检测SP-B、TGF-β1 mRNA表达。结果Ⅰ组大鼠肺泡结构正常,无炎性细胞浸润;Ⅱ组大鼠肺组织结构紊乱,肺泡内有出血、液体渗出;Ⅲ组大鼠肺组织形态及结构改变均较Ⅱ组明显减轻。ELISA法检测SP-B表达:14d时Ⅰ组为(29.93±6.40)ng/L,Ⅱ组为(18.20±3.70)ng/L,Ⅲ组为(19.63±10.20)ng/L;Ⅱ组表达较Ⅰ组明显减少,差异有统计学意义(t=13.152,P〈0.01);Ⅲ组表达较Ⅱ组明显增多,差异有统计学意义(t=5.190,P〈0.01)。TGF-β1表达:14d时Ⅰ组为(34.73±2.30)ug/L,Ⅱ组为(41.66±1.80)ug/L,Ⅲ组为(38.03±0.20)ug/L;Ⅱ组表达较Ⅰ组明显增多,差异有统计学意义(t=6.584,P〈0.01);Ⅲ组表达较Ⅱ组明显减少,差异有统计学意义(t=5.609,P〈0.01)。肺组织RT-PCR检测mRNA表达:SP-BmRNA表达,14d时I组为3.144-0.10,Ⅱ组为0.81±0.06,11组为1.12±0.06;Ⅱ组表达较Ⅰ组明显减少,差异有统计学意义(t=55.050,P〈0.01);Ⅲ组表达较Ⅱ组明显增多,差异有统计学意义(t=10.305,P〈0.01)。TGF-β1 mRNA表达:14d时Ⅰ组为1.94±0.03,Ⅱ组为13.26±0.43,Ⅱ组为6.49±0.26;Ⅱ组表达较Ⅰ组明显增多,差异有统计学意义(t=75.471,P〈0.01);Ⅲ组表达较Ⅱ组明显减少,差异有统计学意义(t=38.470,P〈0.01)。结论环氧合酶-2抑制剂可能通过抑制前列腺素减轻炎性反应,从而缓解高氧下新生大鼠的肺损伤。
Objective To investigate the effects of selective cyclooxygease - 2 inhibitor on pulmonary surfactant protein(SP -B) and transforming growth factor( TGF - β1 ) of hyperoxic lung injury in newborn rats. Methods One hundred and five SD rats were randomly divided into 3 groups (35 cases in each group) :air group( group Ⅰ) ,in which the rats were exposed to room air; hyperoxia group( group Ⅱ), in which the rats were exposed to hyperoxia (850 mL/L oxygen) ;Celecoxib group( group Ⅲ) ,in which the rats were exposed to heyperoxia(850 mL/L oxygen) and intraperitoneally injected with 5 mg/kg Celecoxib. The lungs of rats were removed on 3 d,7 d,14 d after birth and the following indices were measured:lung section from the lower fight lung were stained with HE, and the histological changes was examined; the contents of SP - B and TGF - β1 in the bronehoalveolar lavage fluid of left lung was determinated by using enzyme - linked immunosorbent assay(ELISA);fight upper lung was immunohistochemically stained to measure the contents of SP- B and TGF- β1 ,quantitative real- time PCR( RT- PCR) was used to detect the mRNA expression of SP- B and TGF - β1. Results There were no inflammatory cells and exudation in the lung in group Ⅰ ;in group Ⅱ, the structure disorder, pulmonary edema, and inflammatory infiltrates were found;but the damage was obviously alleviated in group Ⅲ. Protein expression could be better detected by ELISA, at the time of 14 day, SP - B was expressed at different levels in3 groups:(29.93 ±6.40) ng/L in group Ⅰ ,(18.20±3.70) ng/L in group Ⅱ and (19.63 ±10.20) ng/L in group Ⅲ, SP - B level in group Ⅱ was significantly lower than that in group Ⅰ ( t = 13. 152, P 〈 0.01 ), and the expression in group Ⅲ was significantly higher than that in group Ⅱ (t =5. 190,P 〈0.01 ). TGF - β1 was expressed at different levels in3 groups:(34.73 ±2.30) μg/L in group Ⅰ ,(41.66 ±1.80) u/L in group Ⅱ and (38.03 ±0.20) μg/L in group Ⅲ ,and the level of TGF - β1 was significantly higher in group Ⅱ than that in group Ⅰ (t =6. 584,P 〈 0.01 ) ,but the expression of group m was significantly lower than that in group Ⅱ (t =5. 609,P 〈0.01 ). The expression of mRNA was detected by RT - PCR, and at the time of 14 day, SP - B mRNA was expressed at different levels in 3 groups:3.14±0. 10 in group Ⅰ ,0.81 ±0.06 in group Ⅱ and 1.12 ±0.06 in group Ⅲ ,and SP -B level in group Ⅱ was significantly lower than that in the group Ⅰ ( t = 55. 050, P 〈 0.01 ) , and the expression in group Ⅲ was significantly higher than that in group Ⅱ ( t = 10. 305, P 〈 0.01 ). TGF - β1 mRNA was expressed at different levels in the 3 groups : 1.94 ± 0.03 in group Ⅰ , 13.26 ± 0.43 in group Ⅱ and 6.49 ± 0.26 in group Ⅲ, the level of TGF - β1 was significantly higher in group H than that in group Ⅰ ( t = 75. 471, P 〈 0.01 ), while the expression of group IU was significantly lower than that in group Ⅱ ( t = 38.470, P 〈 0. 01 ). Conclusions Cyclooxygenase - 2 inhibitor can attenuate hypemxic lung injury in rats,and the mechanism might be related to the reduction of prostaglandin.
出处
《中华实用儿科临床杂志》
CSCD
北大核心
2016年第14期1081-1085,共5页
Chinese Journal of Applied Clinical Pediatrics